Literature DB >> 23071226

Methodology for comparative effectiveness research: potential and limitations.

Edward L Korn, Boris Freidlin.   

Abstract

Mesh：

Year:  2012        PMID： 23071226     DOI： 10.1200/JCO.2012.44.8233

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Response.

Authors:  Boris Freidlin; Edward L Korn
Journal:  J Natl Cancer Inst       Date:  2014-03-21       Impact factor: 13.506

2.  Improving trial generalizability using observational studies.

Authors:  Dasom Lee; Shu Yang; Lin Dong; Xiaofei Wang; Donglin Zeng; Jianwen Cai
Journal:  Biometrics       Date:  2021-12-04       Impact factor: 1.701

3.  Comparative effectiveness research in oncology.

Authors:  Gary H Lyman
Journal:  Oncologist       Date:  2013-05-22

Review 4.  Considerations for observational research using large data sets in radiation oncology.

Authors:  Reshma Jagsi; Justin E Bekelman; Aileen Chen; Ronald C Chen; Karen Hoffman; Ya-Chen Tina Shih; Benjamin D Smith; James B Yu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-09-01       Impact factor: 7.038

5.  Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.

Authors:  Clara Natoli; Patrizia Vici; Isabella Sperduti; Antonino Grassadonia; Giancarlo Bisagni; Nicola Tinari; Andrea Michelotti; Germano Zampa; Stefania Gori; Luca Moscetti; Michele De Tursi; Michele Panebianco; Maria Mauri; Ilaria Ferrarini; Laura Pizzuti; Corrado Ficorella; Riccardo Samaritani; Lucia Mentuccia; Stefano Iacobelli; Teresa Gamucci
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-20       Impact factor: 4.553

6.  Eribulin mesylate in pretreated breast cancer patients: a multicenter retrospective observational study.

Authors:  Teresa Gamucci; Andrea Michelotti; Laura Pizzuti; Lucia Mentuccia; Elisabetta Landucci; Isabella Sperduti; Luigi Di Lauro; Alessandra Fabi; Giuseppe Tonini; Valentina Sini; Nello Salesi; Ilaria Ferrarini; Angela Vaccaro; Ida Pavese; Enzo Veltri; Luca Moscetti; Paolo Marchetti; Patrizia Vici
Journal:  J Cancer       Date:  2014-03-20       Impact factor: 4.207

7.  Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Carcinoma: A Real-World Study.

Authors:  Mengmeng Zhang; Ling Li; Shiyong Zhang; Wenlong Zhu; Senguo Yang; Guangsheng Di; Xiaoxia Ma; Haisong Yang
Journal:  Biomed Res Int       Date:  2020-05-02       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.